Cheviot Value Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Sell
7,252
-2,175
-23% -$208K 0.06% 75
2025
Q4
$950K Sell
9,427
-88,892
-90% -$8.63M 0.09% 62
2025
Q3
$9.17M Sell
98,319
-673
-0.7% -$61.9K 0.97% 26
2025
Q2
$9.19M Sell
98,992
-644
-0.6% -$54.6K 1.05% 25
2025
Q1
$8.31M Buy
99,636
+12,692
+15% +$1.14M 1.02% 26
2024
Q4
$6.95M Buy
86,944
+2,885
+3% +$250K 1.33% 23
2024
Q3
$7.57M Sell
84,059
-3,185
-4% -$268K 1.43% 23
2024
Q2
$6.87M Buy
87,244
+4,500
+5% +$369K 1.34% 23
2024
Q1
$7.21M Buy
82,744
+3,831
+5% +$327K 1.58% 20
2023
Q4
$6.55M Buy
78,913
+10,318
+15% +$786K 1.41% 23
2023
Q3
$5.38M Buy
68,595
+2,240
+3% +$188K 1.19% 23
2023
Q2
$5.85M Buy
66,355
+4,066
+7% +$350K 1.27% 23
2023
Q1
$5.02M Buy
62,289
+11,273
+22% +$919K 1.21% 24
2022
Q4
$4.01M Buy
51,016
+3,352
+7% +$272K 0.99% 26
2022
Q3
$3.85M Buy
47,664
+407
+0.9% +$36.6K 1.05% 26
2022
Q2
$4.24M Buy
47,257
+1,070
+2% +$108K 1.06% 26
2022
Q1
$5.12M Buy
46,187
+8,691
+23% +$918K 1.08% 27
2021
Q4
$3.88M Sell
37,496
-210
-0.6% -$24.3K 0.91% 31
2021
Q3
$4.73M Sell
37,706
-1,046
-3% -$135K 1.21% 26
2021
Q2
$4.81M Sell
38,752
-5,080
-12% -$638K 1.18% 26
2021
Q1
$5.18M Sell
43,832
-987
-2% -$116K 1.44% 22
2020
Q4
$5.25M Sell
44,819
-466
-1% -$51.3K 1.58% 22
2020
Q3
$4.71M Buy
45,285
+51
+0.1% +$5.12K 1.63% 19
2020
Q2
$4.15M Sell
45,234
-3,967
-8% -$380K 1.62% 18
2020
Q1
$4.44M Sell
49,201
-2,527
-5% -$269K 2.02% 14
2019
Q4
$5.87M Sell
51,728
-535
-1% -$58.7K 2.26% 14
2019
Q3
$5.68M Sell
52,263
-209
-0.4% -$21.8K 2.42% 12
2019
Q2
$5.11M Buy
52,472
+479
+0.9% +$43.7K 2.21% 14
2019
Q1
$4.74M Buy
51,993
+444
+0.9% +$39.7K 2.3% 13
2018
Q4
$4.69M Sell
51,549
-6,483
-11% -$606K 2.44% 11
2018
Q3
$5.71M Sell
58,032
-973
-2% -$90K 2.68% 9
2018
Q2
$5.05M Sell
59,005
-335
-0.6% -$28K 2.48% 11
2018
Q1
$4.76M Sell
59,340
-5,909
-9% -$487K 2.48% 10
2017
Q4
$5.27M Sell
65,249
-1,303
-2% -$104K 2.73% 11
2017
Q3
$5.18M Sell
66,552
-349
-0.5% -$29K 2.81% 11
2017
Q2
$5.94M Sell
66,901
-10,374
-13% -$875K 3.46% 9
2017
Q1
$6.22M Buy
77,275
+4,270
+6% +$334K 3.51% 8
2016
Q4
$5.2M Buy
73,005
+302
+0.4% +$23.7K 3.11% 10
2016
Q3
$6.28M Sell
72,703
-1,375
-2% -$120K 3.9% 9
2016
Q2
$6.43M Sell
74,078
-2,126
-3% -$172K 3.84% 9
2016
Q1
$5.71M Sell
76,204
-6,387
-8% -$481K 3.65% 10
2015
Q4
$6.35M Sell
82,591
-20,966
-20% -$1.58M 4.12% 9
2015
Q3
$6.93M Sell
103,557
-3,373
-3% -$248K 4.61% 7
2015
Q2
$7.92M Sell
106,930
-1,818
-2% -$139K 4.68% 7
2015
Q1
$8.48M Sell
108,748
-4,643
-4% -$352K 5% 6
2014
Q4
$8.19M Sell
113,391
-4,728
-4% -$328K 4.77% 7
2014
Q3
$7.32M Sell
118,119
-4,397
-4% -$280K 4.25% 9
2014
Q2
$7.81M Sell
122,516
-1,711
-1% -$104K 4.17% 9
2014
Q1
$7.64M Sell
124,227
-9,296
-7% -$541K 4.22% 9
2013
Q4
$7.66M Sell
133,523
-4,580
-3% -$260K 4.23% 9
2013
Q3
$7.35M Sell
138,103
-6,020
-4% -$324K 4.06% 9
2013
Q2
$7.42M Buy
+144,123
New +$7.12M 4.05% 9

Other funds holding MDT

Cheviot Value Management's MDT Position: Q1 2026 in Review

Cheviot Value Management reduced its Medtronic (MDT) stake by 23% in Q1 2026, selling an estimated $208K and leaving 7,252 shares worth $628K. The position accounts for 0.06% of the portfolio, ranked #75.

Cheviot Value Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.19M in Q2 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cheviot Value Management held 7,252 shares of Medtronic worth $628K as of Q1 2026.
  • Cheviot Value Management sold 2,175 Medtronic shares in Q1 2026, an estimated $208K.
  • Medtronic made up 0.06% of Cheviot Value Management's portfolio in Q1 2026, its #75 holding.
  • Cheviot Value Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Cheviot Value Management's Medtronic position peaked at $9.19M in Q2 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cheviot Value Management's 13F filing for Q1 2026, filed 12 May 2026.